Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoChange DetectedA 403 Forbidden error page now appears for the study record, replacing the previous detailed study information and associated documents.SummaryDifference19%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page. This update does not change the study content or data presented.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor backend/content-management update without altering the study’s content.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page footer revision label changed from v3.6.3 to v3.6.4, signaling a minor content update to the Study Details page. It does not affect the study information or how the page functions.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision banner updated from v3.6.2 to v3.6.3, indicating a minor internal update to the study page. It does not modify any study details, eligibility criteria, or results.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, representing a small software revision.SummaryDifference0.1%

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.